Molecular Contrast Optical Coherence Tomography and Its Applications in Medicine
- PMID: 35328454
- PMCID: PMC8949853
- DOI: 10.3390/ijms23063038
Molecular Contrast Optical Coherence Tomography and Its Applications in Medicine
Abstract
The growing need to understand the molecular mechanisms of diseases has prompted the revolution in molecular imaging techniques along with nanomedicine development. Conventional optical coherence tomography (OCT) is a low-cost in vivo imaging modality that provides unique high spatial and temporal resolution anatomic images but little molecular information. However, given the widespread adoption of OCT in research and clinical practice, its robust molecular imaging extensions are strongly desired to combine with anatomical images. A range of relevant approaches has been reported already. In this article, we review the recent advances of molecular contrast OCT imaging techniques, the corresponding contrast agents, especially the nanoparticle-based ones, and their applications. We also summarize the properties, design criteria, merit, and demerit of those contrast agents. In the end, the prospects and challenges for further research and development in this field are outlined.
Keywords: molecular contrast OCT; molecular contrast agent; molecular imaging; nanoparticles; optical coherence tomography.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Yue L., Wang J., Dai Z., Hu Z., Chen X., Qi Y., Zheng X., Yu D. pH-Responsive, Self-Sacrificial Nanotheranostic Agent for Potential In Vivo and In Vitro Dual Modal MRI/CT Imaging, Real-Time, and In Situ Monitoring of Cancer Therapy. Bioconjugate Chem. 2017;28:400–409. doi: 10.1021/acs.bioconjchem.6b00562. - DOI - PubMed
-
- Beik J., Jafariyan M., Montazerabadi A., Ghadimi-Daresajini A., Tarighi P., Mahmoudabadi A., Ghaznavi H., Shakeri-Zadeh A. The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: Radiation dose reduction and image contrast enhancement. Artif. Cells Nanomed. Biotechnol. 2018;46:1993–2001. doi: 10.1080/21691401.2017.1408019. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
